Standardized Patients to Measure and AddressIntersectional Stigma: An HIV Prevention Engagement Strateg

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043939

Enrollment

Unknown

Registered

2021-03-06

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STD and HIV

Interventions

Control Arm:Baseline Survey

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) formal government accreditation as a medical center (a basic tenet of all public hospitals in China); and 2) possession of an accredited on-site laboratory with capacity to provide enzyme-linked immunosorbent assay testing for HIV, treponemal (e.g. Treponema pallidum particle agglutination) and non-treponemal tests (e.g. rapid plasma regain) for syphilis. Within eligible and consenting facilities, eligible providers will be those who are licensed at the time of the study to practice dermatovenereology in China.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
stigma enacted by providers attributable to the HIV infection status or male same sex behaviors of the patient;	—

Contacts

Public ContactKumi Smith

smi00831@umn.edu+86 20-6123013051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026